Xilio Therapeutics Inc.

NASDAQ: XLO · Real-Time Price · USD
0.70
0.02 (3.20%)
At close: Jun 06, 2025, 3:59 PM
0.70
0.63%
After-hours: Jun 06, 2025, 05:11 PM EDT

Xilio Therapeutics Statistics

Share Statistics

Xilio Therapeutics has 51.78M shares outstanding. The number of shares has increased by 40.26% in one year.

51.78M
40.26%
17.78%
40.74%
n/a
174,713
14.01%

Short Selling Information

The latest short interest is 1.22M, so 2.35% of the outstanding shares have been sold short.

1.22M
2.35%
3.44%
1

Valuation Ratios

The PE ratio is -0.88 and the forward PE ratio is -0.83. Xilio Therapeutics's PEG ratio is 0.01.

-0.88
-0.83
8.06
3.5
2.9
-2.78
0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Xilio Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.46.

2.21
2.21
0.46
-0.14
-0.44
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$99,125
$-910,015.62
64
0.09
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -34.31% in the last 52 weeks. The beta is 0.02, so Xilio Therapeutics's price volatility has been higher than the market average.

0.02
-34.31%
0.78
0.89
42.39
1,246,853

Income Statement

In the last 12 months, Xilio Therapeutics had revenue of 6.34M and earned -58.24M in profits. Earnings per share was -1.09.

6.34M
4.7M
-60.58M
-58.24M
-56.5M
-59.65M
-1.09
Full Income Statement

Balance Sheet

The company has 55.29M in cash and 8.14M in debt, giving a net cash position of 47.15M.

55.29M
8.14M
47.15M
-383.75M
103.72M
45.56M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.38M and capital expenditures -36K, giving a free cash flow of -18.41M.

-18.38M
-36K
-18.41M
-0.34
Full Cash Flow Statement

Margins

Gross margin is 74.09%, with operating and profit margins of -954.95% and -918.05%.

74.09%
-954.95%
-918.05%
-918.05%
-890.56%
-954.95%
-290.26%

Dividends & Yields

XLO does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for XLO is $4, which is 497% higher than the current price. The consensus rating is "Buy".

$4
497%
Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-6.23
4